权威例句
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysisAddition of low‐dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patientsThe PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarctionAn International Study of the Effects of Rosiglitazone plus Sulphonylurea in Patients with Type 2 DiabetesThe Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling PathwaysThe effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients wit...A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 d...